(PharmaNewsWire.Com, February 01, 2024 ) The report "Blood Culture Tests Market by Method (Conventional, Automated), Product (Consumables, Instruments), Technology (Culture, Molecular, Proteomics), Application (Bacteremia, Fungemia), End User (Hospitals, Reference Labs) & Region- Global Forecast to 2028", is projected to reach USD 7.6 billion by 2028 from USD 5.2 billion in 2023, at a CAGR of 8.0% during the forecast period. Growth in this market is primarily fueled by growing demand for rapid diagnostic techniques, high prevalence of infectious diseases , growing incidence of sepsis cases and high cost treatment, rising geriatric population and high incidence of bloodstream infections. Alternatively, lack of trained laboratory technicians and high cost of automated instruments are expected to restrain the market growth in the upcoming years.
The Automated Blood Culture Tests segment is expected to grow the highest during the forecast period
Based on method, conventional/manual blood culture and automated blood culture methods are the different blood culture tests market segments. The automated blood culture segment is expected to grow the highest during the forecast period. The quick turnaround time and reduced risk of contamination due to low manual intervention drives the growth of the automated blood culture method segment in the blood culture tests market.
The Consumables segment is expected to grow the highest during the forecast period
Based on product, the consumables, instruments, and software and services, make up the major market segments for blood culture tests market. The consumables segment not only has the largest share but is also expected to grow the highest during the forecast period. The large share of this segment is attributed to the repeated purchase of media for the detection of bacteria, fungi, and yeast and increase in drug-resistant infections, such as methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL)-producing bacteria.
The Molecular Technologies segment is to witness the highest growth during the forecast period
Based on technology, the blood culture tests market is categorized into distinct segments, including molecular technologies, proteomics and culture-based technologies. Among these, molecular technologies segment is to witness the highest growth during the forecast period. This can be attributed to several factors, such as the increasing incidence of sepsis, which demands rapid diagnostic techniques for detecting the presence of fungi, bacteria, and mycobacteria from blood samples.
The Bacteremia segment is expected to look for the highest growth during the forecast period
Based on application, the market for blood culture tests is divided into fungemia, mycobacterial detection and bacteremia. Bacteremia segment is expected to look for the highest growth in the blood culture tests market. The highest growth of this segment is primarily attributed to the increasing number of bloodstream infections and the growing number of sepsis cases worldwide.
The Hospital Laboratories segment has accounted for the largest share during the forecast period
Based on end users, the bloodculture tests market is bifurcated into reference laboratories,hospital laboratories, academic research laboratories, and other laboratories (includes physician office laboratories (POLS), pathology laboratories, independent research laboratories and bacteriological laboratories). The hospital laboratories segment has accounted for the largest share in this market. This is due to the rising number of sepsis cases in emergency departments (EDs), as sepsis is most commonly observed in EDs.
Asia-Pacific is to witness the highest growth during the forecast period.
The Asia-pacific blood culture tests market is expected to grow at the highest CAGR during the forecast period of 2023-2028. The high growth rate of this market can be attributed to the high prevalence of sepsis and government initiatives to increase its awareness, increasing demand for effective diagnostic techniques, and growing regulatory approvals and availability of blood culture test products in the region.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: